REFERENCES
- National Hemoglobinopathy Cooperative Study Group. A survey of hemoglobinopathies in 600,000 peoples from 20 provinces, autonomous regions and municipalities. Chin J Med. 1983; 64(6):382–385.
- Ko TM, Xu X. Molecular study and prenatal diagnosis of α- and β-thalassaemia in Chinese hemoglobin. J Formos Med Assoc. 1998;97(1):5–15.
- Orkin SH, Karazian HH Jr. The mutation and polymorphism of the human β-globin gene and its surrounding DNA. Ann Rev Genet. 1984;18:131–171.
- Kazazian HH Jr. The thalassemia syndromes: molecular basis and prenatal diagnosis in 1990. Semin Hematol. 1990;27(3):209–228.
- Li D, Liao C, Li J, Prenatal diagnosis of β-thalassemia by reverse dot-blot hybridization in southern China. Hemoglobin. 2006;30(3):365–370.
- Liao C, Mo QH, Li J, Carrier screening for α- and β-thalassemia in pregnancy: the results of an 11-year prospective program in Guangzhou Maternal and Neonatal Hospital. Prenat Diagn. 2005;25(2):163–171.
- Winichagoon P, Saechan V, Sripanich R, Nopparatana C, Kanokpongsakdi S, Maggio A. Prenatal diagnosis of β-thalassemia by reverse dot-blot hybridization. Prenat Diagn. 1999;19(5):428–435.
- Lau YL, Chan LC, Chan YY, Prevalence and genotypes of α- and β-thalassemia carriers in Hong Kong – implications for population screening. N Engl J Med. 1997;336(18):1314–1316.
- Yi P, Chen Z, Zhao Y, PCR/LDR/capillary electrophoresis for detection of single-nucleotide differences between fetal and maternal DNA in maternal plasma. Prenat Diagn. 2009;29(3):217–222.